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Abstract
Oestrogens are well-known proliferation and differentiation factors that play an 
essential role in the correct development of sex-related organs and behaviour in 
mammals. With the use of the ERE-Luc reporter mouse model, we show herein that 
throughout mouse development, oestrogen receptors (ERs) are active starting from day 
12 post conception. Most interestingly, we show that prenatal luciferase expression in 
each organ is proportionally different in relation to the germ layer of the origin. The 
luciferase content is highest in ectoderm-derived organs (such as brain and skin) and is 
lowest in endoderm-derived organs (such as liver, lung, thymus and intestine). Consistent 
with the testosterone surge occurring in male mice at the end of pregnancy, in the first 
2 days after birth, we observed a significant increase in the luciferase content in several 
organs, including the liver, bone, gonads and hindbrain. The results of the present study 
show a widespread transcriptional activity of ERs in developing embryos, pointing to 
the potential contribution of these receptors in the development of non-reproductive as 
well as reproductive organs. Consequently, the findings reported here might be relevant 
in explaining the significant differences in male and female physiopathology reported 
by a growing number of studies and may underline the necessity for more systematic 
analyses aimed at the identification of the prenatal effects of drugs interfering with ER 
signalling, such as aromatase inhibitors or endocrine disrupter chemicals.
Introduction
Oestrogens have been long known as cell proliferation 
and differentiation factors (Tsai & O’Malley 1994), and 
several lines of evidence suggest that, in the course 
of foetal programming, these hormones are relevant 
for the sexual differentiation of reproductive tissues, 
including the brain (Phoenix et al. 1959, Pang et al. 1979, 
Tobet et al. 1986, Korach et al. 1988, Greco et al. 1991, 
Rissman et al. 1997, Nielsen et al. 2000, Albrecht et al. 
2009). Very little is known regarding the effects of these 
steroids in non-reproductive organs, in spite of the fact 
that preclinical and clinical investigations in subjects 
with prenatal impairment of ER signalling showed 
physiological alterations and increased incidence of 
diseases involving the cardiovascular (Conte et al. 1994, 
Jones et  al. 2000, Tait et  al. 2015, Yuchi et  al. 2015), 
metabolic (Lapid et al. 2014), immune (Zoller & Kersh 
2006), respiratory (Thuresson-Klein et  al. 1985), and 
skeletal systems as well as the epidermis (Hanley et al. 
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1996, Brandenberger et  al. 1997, Lemmen et  al. 1999, 
Takeyama et al. 2001).
The biological effects of the steroid hormone 
17β-oestradiol (E2) – the most expressed oestrogen – are 
predominantly mediated through two distinct ERs (ERα 
and ERβ) that share a common phylogenetic origin, 
conserved structural organization and similar mode of 
action (mainly as ligand-operated transcription factors) 
with the other members of the nuclear receptor (NR) 
family (Tsai & O’Malley 1994, Kininis & Kraus 2008). In 
addition, ERs may interfere with the signalling of other 
membrane receptors as well as intracellular receptors, 
and ERα, may associate with the plasma membrane and 
may activate non-nuclear signalling from this site. These 
rapid, non-genomic/membrane initiated steroid signals 
have been characterized in endothelial cells but may be 
present in other cellular systems (Arnal et al. 2017). The 
functional activation of intracellular ERs occurs through 
binding with oestrogens, but unliganded ER activation 
may be triggered by enzymatic activities, inducing post-
translational modifications (Dahlman-Wright et al. 2006) 
that enable ER to release inhibitory proteins generally 
associated with inactive receptor proteins. ERs were the 
first NRs to be described (Toft & Gorski 1966, Jensen 2005), 
and they appear to be the closest to the ancestral steroid 
receptor (Thornton et  al. 2003). In addition to these 
intracellular proteins, a membrane receptor, G protein-
coupled oestrogen receptor 1 (GPER1), may transduce 
oestrogen signals through non-genomic signalling 
(Revankar et al. 2005).
In adult mammals, it is well known that ERs are 
expressed and functionally active in most reproductive 
and non-reproductive tissue cells (Ciocca & Roig 1995, 
Maggi et al. 2004, Bookout et al. 2006). Their expression 
and transcriptional activity in the course of embryo 
development is less studied (Brandenberger et  al. 1997, 
Lemmen et al. 1999). In addition to selective KO mutation 
of ERα, ERβ or the aromatase gene (Cyp19a1, encoding the 
enzyme responsible for testosterone-derived oestrogen 
synthesis) that highlighted the relevance of these 
receptors and their cognate ligands for the development 
of sexual organs and sexual behaviour (Kudwa et al. 2006), 
the elucidation of the ER distribution and activity during 
implantation and embryogenesis in non-reproductive 
tissues is circumscribed to only a few studies (Bondesson 
et al. 2015, Mogi et al. 2015, Park et al. 2017). However, 
preclinical and clinical observations in subjects carrying 
mutations that impair ER signalling showed deviations 
from the proper development of the cardiovascular 
system (Del Principe et  al. 2015, Tait et  al. 2015), 
innate immune and neuro-immune communications 
(Zoller & Kersh 2006), pancreatic and gastric activity 
(Campbell-Thompson et al. 2001, Maniu et al. 2016) and 
liver functions (Bryzgalova et al. 2006, Foryst-Ludwig et al. 
2008, Barros & Gustafsson 2011), as well as adipose (Barros 
& Gustafsson 2011, Lapid et al. 2014), lung (Thuresson-
Klein et al. 1985, Patrone et al. 2003, Carey et al. 2007), 
kidney (Lane 2008, Kummer et  al. 2011) and epidermal 
tissues with the muscle-skeletal apparatus (Hanley et  al. 
1996, Brandenberger et  al. 1997, Lemmen et  al. 1999, 
Takeyama et al. 2001, Walker & Korach 2004, Markiewicz 
et al. 2013, Ueberschlag-Pitiot et al. 2017).
In view of the growing number of reports pointing 
to significant sex-related differences in mammalian 
physiopathology and the increasing concern of the 
potential long-term effects of maternal exposure to EDCs 
and to drugs (such as aromatase inhibitors) that may 
interfere with oestrogen signalling during pregnancy, 
a better understanding of the oestrogen-dependent 
programmes in ontogeny is indispensable for the 
comprehension of the role of sex in the incidence of 
several pathologies and for the creation of efficacious 
protocols for the evaluation of EDCs exposure.
To verify the extent of ER transcriptional activity 
during embryogenesis, we investigated the luciferase 
expression in the ERE-Luc reporter mouse (Ciana et  al. 
2001, 2003). In this mouse, the general transcription of the 
firefly luciferase transgene is controlled by the activated 
intracellular ERs. In the last 15 years, a large number of 
studies carried out in different laboratories showed that, in 
the ERE-Luc mouse, the amount of luciferase synthesized 
is proportional to the ER transcriptional activity and 
quantifiable in vivo by bioluminescence imaging or ex 
vivo by means of an enzymatic assay in tissue lysates 
(Klotz et al. 2002, Patrone et al. 2003, Humpel et al. 2005, 
Mussi et al. 2006, Chambliss et al. 2010, Penza et al. 2011, 
Vantaggiato et  al. 2016). These studies demonstrated 
(i) a lack of interference of signals originating by the 
chromatin surrounding the transgene granted by the 
combination of the specific integration site and insulator 
sequences flanking the reporter (Rizzi et  al. 2017), (ii) 
the selective response to ERs of the synthetic promoter 
driving luciferase transcription and (iii) that the reporter 
is transcriptionally viable in all tissues (as also indicated 
by a background reporter activity due to the TK minimal 
promoter).
By demonstrating that ERs are widely active during 
embryo development, our results will facilitate the 
understanding of complex functions of ERs in embryo 
maturation, putting novel bases for the comprehension of 
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the involvement of sex in the incidence and progression 
of pathologies not strictly associated with reproductive 
functions. The data presented may also help with the 
prediction of the effects of exposure to EDCs or the 
administration of drugs, such as aromatase inhibitors to 
pregnant mothers. Therefore, the ERE-Luc reporter mice 
may be considered a valuable tool to unravel the effects 
of potential EDCs or drugs administered to pregnant 
mothers that can interfere with the oestrogen signalling 
of the foetus.
Materials and methods
Animals
The mice were housed with ad libitum access to standard 
chow (RF21, Mucedola, Italy) and water. We generated 
heterozygous ERE-Luc foetuses by caging homozygous 
ERE-Luc males with WT C57/Bl6j females for the night. 
The day after overnight mating was counted as 0.5 dpc 
(day post conception). Natural birth occurred on 19.5 dpc, 
which was counted as day 0 post birth (P0). In the 
experiments with the knockouts, the mice heterozygous 
for aromatase (Ar+/−) from E. Simpson were crossed 
with ERE-Luc mice, and the progeny were as backcrossed 
to obtain both KO and WT foetuses in the same litter 
that were genotyped from tail-derived DNA by PCR 
using published primers (Fisher et al. 1998). The sex was 
confirmed by PCR of the SMC locus (Agulnik et al. 1997). 
All the animal experiments were carried out in accordance 
with the European Guidelines for human animal care. The 
use of experimental animals was approved by the Italian 
Ministry of Research and University and was controlled by 
the panel of experts of the Department of Pharmacological 
and Biomolecular Sciences at the University of Milan.
Treatment with ER antagonist
ICI 182,780 powder (Sigma) was dissolved in 99% v/v 
ethanol to a concentration of 30 mg/mL. A total of 75 µg 
or 30 µg of ICI, dispersed in 100 µL of maize oil, was s.c. 
injected 24 h and 6 h before the imaging session, resulting 
in 1 mg/kg and 2.5 mg/kg for a 33 g female at day ~16 of 
pregnancy.
In vivo bioluminescence imaging
Pregnant females were anaesthetized with 50 µL s.c. 
injection of a water solution of 78% ketamine (Ketavet 
50 mg/mL, Intervet, Peschiera Borromeo, Italy) and 
15% xylazine (Rompun 20 mg/mL, Bayer, Leverkusen, 
Germany). Once anaesthetized, the pregnant females 
were shaved to allow a better measurement of the photons 
emitted from the foetuses. Fifteen minutes before BLI, 
90 µL of a water solution of the luciferase substrate 
luciferin (Beetle luciferin potassium salt, Promega) 
was administered s.c. (75 mg/kg). Bioluminescence 
was measured by a Night Owl imaging unit (Berthold 
Technologies, Bad Wildbad, Germany); the mice were 
placed in the light-tight chamber, and their pictures 
were first taken with dimmed light, and then the 
luciferase signal was registered for 5 min. Merging of the 
images enabled to visualizing body areas where photon 
emission occurred (luciferase signal was transformed 
in pseudocolours: blue-lowest, then green, red, yellow 
and white as the highest signal). For quantification, 
photon emission was measured in the whole body areas 
(counts per second, cts/s). Normalization was performed 
using an external source of photons (Glowell, Lux 
Biotechnology, Edinburgh, UK) enabling measurement 
of the instrumental efficiency of photon counting. All 
the measurements were performed using WinLight32 
(Berthold Technologies). After BLI, the foetuses were 
dissected under binocular macroscopy, and the organs 
shown in the figures were collected, frozen on dry-ice and 
stored at −80°C until assayed.
Luciferase enzymatic assay
The tissues were homogenized in 200 µL ice-cold lysis 
buffer (100 mM KPO4, 1 mM DTT, 4 mM EGTA, 4 mM 
EDTA, pH 7.8) with a micro pestle (Eppendorf); then, 
they underwent freezing and were thawed during 
centrifugation at 4900 g, 4°C for 25 min. The supernatants 
were collected, and the protein concentrations were 
measured by Bradford assay following the manufacturer’s 
instructions (Pierce Biotech). Luciferase enzymatic activity 
was measured with a commercial kit (Luciferase Assay 
System, Promega) in a luminometer (Glomax, Promega) 
and was expressed as the relative light units over 10 s/µg 
protein (RLU/µg proteins).
Immunohistochemistry
The mice at 17.5 dpc were fixed in 4% paraformaldehyde, 
embedded in paraffin and whole-sliced. Sections of 
5 µm were deparaffinized in xylene and rehydrated in 
decreasing ethanol concentrations. After washing, the 
slides were microwaved in citrate buffer, washed in PBS 
and incubated 15 min in 1% H2O2.
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For luciferase detection: After three PBS washes, the 
sections were permeabilized in 0.2% Triton-X-100 in PBS 
and blocked by incubation with 10% goat serum and 0.3% 
Tween 20 in PBS for 30 min at 37°C, followed by biotin 
blocking buffer (Vector Laboratories). The sections were 
incubated in a humidity chamber overnight at 4°C with 
rabbit anti-luciferase antibody or normal rabbit serum 
diluted 1:6000 in blocking buffer. The anti-luciferase 
antibody was provided by W Just (Soto et al. 1993). Next, 
the sections were washed in 0.3% Tween 20 PBS and 
were incubated at room temperature for 60 min with 
biotinylated goat anti-rabbit IgG (Vector Laboratories) 
and diluted 1:200 in 1% normal goat serum 0.3% Tween 
20. Detection was performed with the Vectastain ABC 
kit (Vector Laboratories) according to the manufacturer’s 
instructions. The sections were counterstained with 
haematoxylin/eosin.
For ERα detection: After three PBS washes, the sections 
were permeabilized and blocked by incubation with 
10% goat serum, 0.3% Triton-X in PBS for 120 min at RT, 
followed by biotin blocking buffer (Vector Laboratories). 
The sections were then incubated in a humidity chamber 
overnight at 4°C with anti-ERα antibody (polyclonal, 
made in rabbit, Abcam ab75635) or normal rabbit serum 
was diluted 1:100 in blocking buffer. Next, the sections 
were washed in 0.3% Tween 20 PBS and were incubated 
at room temperature for 60 min with biotinylated goat 
anti-rabbit IgG (Vector Laboratories), diluted 1:200 in 1% 
normal goat serum. Detection was performed with the 
Vectastain ABC kit (Vector Laboratories) according to the 
manufacturer’s instructions.
Statistical analysis
P values were calculated as described in the figure 
legends using GraphPad Prism version 5.01 for Windows, 
GraphPad Software.
Results
The in vivo BLI of WT female mice crossed with 
homozygote male ERE-Luc clearly showed luciferase 
activity in living foetuses growing in utero. Figure  1A 
shows that by exposing the pregnant mothers to CCD, 
photon emission from the foetuses was measurable from 
14.5 days post conception (dpc), increasing in the course 
of pregnancy and was highest at 18.5 dpc. Considering 
that the mother tissues shielded some of the embryo 
bioluminescence, to obtain better insight into the onset 
of luciferase synthesis in the embryos, we investigated 
the BLI pattern of ER activity in excised embryos. 
Figure 1
ER is transcriptionally active in the developing mouse. (A) In utero imaging: anaesthetized WT pregnant mothers carrying ERE-Luc foetuses were injected 
with the substrate luciferin 30 min prior to imaging, and photon emission was recorded in BLI units. Merging of the pseudo colour-transformed signal 
with the pregnant picture allows the identification of transcriptional active oestrogen receptors in the developing litter (blue: low, white: high). The 
mothers were shaved to improve photon imaging. (B) Representative BLI taken in living foetuses immediately after uterine excision and of a newborn 
mouse at P1. The sex of the mouse at P1 is male. (C) 24 h and 6 h before litter collection, pregnant females were treated with vehicle or 1 mg/kg or 
2.5 mg/kg of the ER pure antagonist ICI 182,780. Foetuses were excised at 16.5 dpc and were subjected to BLI. Photon emission (cts/cm2 s) was measured 
in the whole (upper) foetal area and was transformed in a pseudocolour image merged on the mice pictures (lower). Bars represent the mean ± s.e.m. 
*P < 0.05 calculated with one-way ANOVA followed by Bonferroni post hoc test.
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Therefore, the mothers were injected with luciferin and 
killed for the dissection and rapid measurement of BLI 
in each individual embryo (Fig.  1B). Photon emission 
was measurable starting at 12.5 dpc but not before. At 
12.5 dpc, photon emission was quite diffuse in the whole 
embryo, with higher emission in the telencephalon, in 
the proximity of the eyes, in the heart and in the spinal 
ganglia. The finding of luciferase activity at 12.5  dpc 
was consistent with gonad differentiation from a 
bipotential to sexually differentiated state (as indicated 
by transcriptome analysis) (Munger et al. 2013) and with 
the highest foetal production of oestrogens (Lemmen 
et  al. 2002). At 13.5  dpc, photon emission was more 
circumscribed to the brain and peripheral nervous 
system. From 16.5 dpc to 18.5 dpc, luciferase emission 
increased from the dorsal to the ventral skin, and one 
day post birth (P1), the signal was maximal in the 
hepatic/abdomen area and in the limbs.
To rule out that oestrogen-related receptors (ERRs), 
which are widely expressed in embryos (Bonnelye et  al. 
1997, Luo et al. 1997), were active on the promoter of the 
ERE-Luc mouse, we treated pregnant females with the 
ER pan-antagonist fulvestrant (ICI 182,780), which has 
been reported to be an agonist of ERRs (Li et  al. 2010). 
Treatment of the mothers with 1 mg/kg and 2.5 mg/kg ICI 
182,780 was associated with a dose-dependent decrease 
in photon emission in foetuses (Fig.  1C), pointing to 
the absence of significant contributions from ERRs to 
luciferase synthesis. To further demonstrate the strict 
association between photon emission and ER-dependent 
luciferase expression, mice at 17.5 dpc were subjected to 
BLI and were subsequently whole-mounted for staining 
with anti-luciferase antibodies. The intensity and 
distribution of the peroxidase staining clearly reproduced 
the BLI (Fig. 2A and B) and enabled the definition of the 
cells expressing the reporter enzyme at the cellular level. 
The specificity of the luciferase staining was tested in 
several tissues of ERE-Luc and WT mice (Fig. 2C, D, E, F, 
G, H and I) and, importantly, the immuno-decoration of 
luciferase reproduced the staining obtained with anti-ERα 
antibodies in several tissues (whole snout, muscle, bone, 
whiskers, skin) (Fig. 2L, M, N, O and P).
This experiment, together with previous BLI 
observations, was a clear indication of the widespread 
ER transcriptional activity. In addition to brain and 
reproductive organs, we found significant amounts of 
luciferase activity in several non-reproductive tissues. The 
overall analysis of luciferase showed very high staining 
in the epidermis and in the hindbrain. With regard 
to the other organs, the staining appeared to follow a 
gradient: highest in ectoderm-derived organs and lowest 
in endodermal organs.
BLI, enabling the measurement of the reporter activity 
in living animals, is extremely useful for the spatio-temporal 
study of a given molecular event in single individuals; 
however, the two dimensional nature of the BLI outcome 
does not allow the exact, quantitative localization of the 
organ responsible for photon emission, as the deeper an 
organ is, the more attenuated the BLI signal, and the photon 
emission measured in a specific surface represents the sum of 
all signals coming from the different layers of tissue (Maggi 
& Ciana 2005). Thus, to better define the organs where ERs 
were most active, we carried out a series of enzymatic assays 
in selected tissue extracts. The measured luciferase activity 
changed significantly in the different organs and ranged 
from 10 RLU/µg protein to 4000 RLU/µg protein. In line 
with what was suggested by prior immunohistochemistry 
analyses, we found a strict correlation between the germ 
layer and the amount of luciferase activity (Fig.  3). The 
highest expression of the reporter was found in ectoderm-
derived organs (brain and skin), while in the endoderm-
derived organs (liver, lung, thymus and intestine), ER 
activity was the lowest. Mesodermic organs (heart, femur, 
gonad and kidney) appeared to have an intermediate 
concentration of the enzyme. Supplementary Figure 1 (see 
section on supplementary data given at the end of this 
article) shows that in the skin, hindbrain and forebrain, 
luciferase is, in general, statistically more expressed than in 
the other tissues.
Next, we stratified the data in relation to sex (Fig. 4). 
No major differences were found prior to birth. The only 
exception was represented by the gonads at 18.5  dpc, 
where females had more luciferase than males, an effect 
possibly associated with the very high expression of ERα 
protein in the ovary (Nielsen et al. 2000) at this embryonal 
stage. At P1, there was a generalized increase in luciferase 
activity in most organs. In the liver, bone, gonads and 
hindbrain, the increase observed in luciferase expression 
was significantly higher in males.
This result was consistent with the fact that male, not 
female, gonads synthesize steroids just prior to and after 
birth and that the testosterone synthesized is aromatized 
to E2 in several organs (Jones et al. 2000). When we crossed 
the ERE-Luc with the aromatase KO mice, we failed to see 
such an effect in male livers and femurs as well as the 
testis and skin of pups at P1 (Fig. 5). In the ArKOxERE-
Luc mice, the luciferase activity was comparable with 
the levels recorded through previous foetal stages (Fig. 3; 
RLU/µg protein: liver 5.67 ± 1.33; femur 42.67 ± 9.28; testis 
6.67 ± 3.67; skin 572 ± 75.50), which provided further 
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support for the hypothesis that the increased activity of 
the reporter observed in males only at P1 was induced 
by the oestrogens derived from the surge of testosterone 
production by male gonads (Clarkson & Herbison 2016). 
In addition, the observation of a basal level of ER activity 
in the different organs of ArKOxERE-Luc mice suggested 
that the unliganded ERs could be activated by factors 
other than circulating oestrogens.
Discussion
The present study demonstrates that, in the course 
of embryogenesis, ER transcriptional activity is not 
restricted to the reproductive organs. Indeed, ERs appear 
to be particularly active in tissues originating from the 
ectoderm, such as the brain and skin and have a lower 
yet still significant action in tissues, such as the gonads, 
Figure 2
Immunostaining reveals ER activity in different tissues. A 17.5 dpc litter was subjected both to BLI and to IHC against luciferase and ERα.  
(A) Representative BLI of one mouse (signal was arithmetically increased with respect to Fig. 1B) and one of its whole-mount sections stained for 
luciferase (B). (C, D, E, F, G, H and I) IHC against luciferase; organ pictures were taken at 100–400× magnification: intestine (C; 100×), heart (D; 400×), 
hindbrain (E; 100×), muscle (F; 400×), rib (G; 400×), whisker follicle (H; 400×), skin (I; 200×). Small panels show the antibody specificity tested on a WT 
mouse. (L, M, N, O and P) IHC against ERα; organ pictures were taken at 100–400× magnification: muscle (L; 400×), rib (M; 400×), nose (N; reconstruction 
of 50×), whisker follicle (O; 400×), skin (P; 200×).
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kidney, bone and hearth, deriving from the mesoderm. 
Quite interesting is the fact that ERs are minimally active 
in endodermic tissues, such as the lung, liver, thymus and 
intestine.
The mechanisms associated with this differential 
pattern of ER activity in the organs studied in relation to 
the germ-layer of origin remain to be defined. An initial 
explanation could be associated with a differential, tissue-
specific expression of the two isoforms of ER. The lack of a 
detailed localization study describing the relative content 
of ERα and ERβ in embryogenesis does not allow us to 
define whether the differences of ER activity observed are 
due to a germ-layer-specific expression of each ER or to 
changes in their relative concentration with consequent 
potential homo- or hetero-dimerization. A second 
potential explanation resides in ligand availability, as it is 
conceivable that, depending of the stage of development, 
the oestrogens produced may have differential ability to 
reach the organs deriving from each of the three germ 
layers. The main source of steroid hormones during 
pregnancy is the maternal-placental-foetal unit (MPF unit) 
(Becker 2001). Measurements of oestrogen concentration 
in maternal blood showed a steady increase throughout 
pregnancy, with a peak at 17.5 dpc (Barkley et al. 1977); in 
the foetus, the peak of oestrogen synthesis is at 12.5 dpc 
(Lemmen et al. 2002). However, to be transported by the 
plasma, these lipophilic molecules associate with the 
alpha-fetoprotein (AFP), and it has been hypothesized that 
the high concentration of AFP produced may sequester 
most of the steroids produced by the MPF and may protect 
the foetus from the effects of maternal steroid hormones 
(Savu et  al. 1981, Mendel 1989, Bakker et  al. 2006, De 
Mees et  al. 2006). Our data clearly show a germ layer-
dependent ER transcriptional activity, which that could 
be due to either the existence of a tissue-specific uptake 
of circulating oestrogens or to ER unliganded activation. 
Indeed, endocytic pathways were described as necessary 
to carry steroids inside the cells (Hammes et al. 2005), but 
we still do not know whether such transport proteins are 
present in the embryo and are localized differentially in 
the various tissues. Alternatively, ERs may be differentially 
activated by means of a localized pattern of expression of 
genes encoding factors known to be able to activate these 
NRs in a unliganded way (such as EGF, IGF or others) 
(Bondy et al. 1990, Partanen 1990).
Regardless of the mechanisms involved, the number 
of tissues where ER is transcriptionally active in the 
course of development is suggestive of a significant 
biological function of the hormone–receptor complex 
in both reproductive and non-reproductive organs. 
Unfortunately, the developmental effects of the deletion 
of genes encoding ERα and ERβ or both isoforms have 
been only slightly investigated. This lack of study is 
possibly due the fact that none of the initial studies 
Figure 3
Foetal ER activity shows lineage-correlation. A 
pattern of ER transcriptional activity in different 
organs was obtained by measuring the luciferase 
activity on tissue lysates (enzymatic assay) 
obtained from the foetuses of both sexes. Each 
column contains organs from different germ 
layers. Bars represent the mean ± s.e.m. (n = 6–10 
foetuses). *P < 0.05, **P < 0.01 vs the previous 
stage calculated by one-way ANOVA followed by 
the Bonferroni post hoc test. nd, not measured.
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described major phenotypes, and both males and females 
survived to adulthood (Lubahn et  al. 1993, Krege et  al. 
1998, Couse et  al. 1999), even with fertility problems, 
which is particularly relevant in the ERα-null mice 
(Krege et al. 1998, Dupont et al. 2000, Walker & Korach 
2004). However, more recent studies carried out in adults 
demonstrated that the deletion of ERα or ERβ is associated 
with malfunctions of several organs considered to be 
non-essential for reproduction, such as the lung, liver, 
adipose tissue, heart, kidney, thymus, bone and skin 
(Brandenberger et al. 1997, Lemmen et al. 1999, Takeyama 
et al. 2001, Walker & Korach 2004, Zoller & Kersh 2006, 
Carey et  al. 2007, Foryst-Ludwig et  al. 2008, Barros & 
Gustafsson 2011, Kummer et  al. 2011, Markiewicz et  al. 
2013, Lapid et al. 2014, Del Principe et al. 2015, Tait et al. 
2015). In the perinatal mouse brain, the spatio-temporal 
expression of ERα and ERβ was reported to contribute 
to organize sex differences that are not associated with 
Figure 5
Lack of aromatase activity regulates ER activity in 
males. ERE-Luc mice were bred with Ar+/− mice, 
and the progeny was backcrossed to obtain the 
same litter Ar−/− and Ar+/+ × ERE-Luc mice. (A) 
Newborn P1 mice were subjected to BLI. (B) 
Luciferase activity was measured in tissue lysates 
(enzymatic assay) in which gender difference was 
previously observed (Fig. 4). Bars represent the 
mean ± s.e.m. (n = 4–6 foetuses). *P < 0.05, **P < 0.01 
vs Ar+/+ × ERE-Luc calculated by one-way ANOVA 
followed by Bonferroni post hoc test.
Figure 4
Gender specificity in ER activity during 
development. The same data shown in Fig. 3 
(luciferase enzymatic assay) were stratified for 
sex. Bars represent the mean ± s.e.m. (n = 4–6). 
*P < 0.05, **P < 0.01 compared with opposite 
gender calculated with unpaired Student’s t test. 
nd, not measured.
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reproduction, such as the stress response and cognition 
(Mogi et al. 2015).
It is conceivable that the sexual dimorphism 
observed in the prevalence, course and severity of many 
common diseases, including cardiovascular diseases, 
autoimmune diseases and asthma, may originate from 
a sex-specific genetic architecture that is created in the 
course of development (also through ER activity) and 
that results in a male and female differential endocrine 
susceptibility and gene regulation, particularly in sex 
steroid-responsive genes. The relevance of oestrogen 
programming mechanisms within the mammalian 
foetus and perinatal time period is underlined by studies 
on liver metabolism that are strictly regulated by sex 
and where the expression and activation of hepatic ER 
in the course of embryo maturation and in adult life 
plays a prominent role (Della Torre et al. 2018) on energy 
metabolism (Yuchi et al. 2015, Maniu et al. 2016), gastric 
functions (Campbell-Thompson et al. 2001), adrenal and 
renal activity (Walker et  al. 2009, Inamdar et  al. 2015), 
cardiovascular activity (Del Principe et  al. 2015) and 
immune functions (Zoller & Kersh 2006).
In conclusion, the results from this study and those 
mentioned above point to a substantial relevance of ER 
signalling for the correct development of mammalian 
embryos, and they highlight the necessity to increase 
our knowledge with more systematic studies aimed 
at understanding the necessity of these hormones, 
particularly for the correct development and functioning 
of non-reproductive organs. Such studies should not 
be confined to prenatal development and pups, but 
should be extended to adults, possibly challenged with 
appropriate stimuli, enabling us to test their ability to 
respond to alimentary and environmental stimuli, with a 
particular emphasis onto endocrine disrupters known to 
preferentially act through ERs.
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